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mediated by a number of humoral agents of both host and microbial origin (1, 2) . 'The control pf the inflammatory response has been a subject of inte'nse study, the progress of which has been facilitated by the availability in recent years of quantitative in vitro assays of PMN chemotaxis. In particular, it has been established that PMN themselves produce agents capable of either augmenting or limiting the chemotactic response. Thus, PMN contain factors which either have direct chemotactic activity (3) (4) (5) (6) (7) (8) or can form chemotactic agents by interacting with the serum complement system (5, (8) (9) (10) (11) (12) (13) (14) (15) (16) , factors which immobili'ze leukocytes, thus preventing the exodus of cells from the inflammatory site (17, 18) , and factors which inactivate chemotactic agents (8, 9, (14) (15) (16) 19) . The focus of the current work is on a specific mechanism by which PMN may modulate inflammation through the myeloperoxidas'ecatalyzed inactivation of leukotactic factors.
Myeloperoxidase, together with hydrogen peroxide and an oxidizable halide cofactor, forms an important microbicidal system of the PMN (2, 20, 21) . Although the primary role of this system is the destruction of microorganisms within the phagocytic vacuole, it has become apparent that it may also participate in extra-cellular reactions. When the PMN is activated by contact with phagocytic particles or immune reactantcoated surfaces or by exposure to certain soluble stimuli, including chemoattractants, exocytosis of cytoplasmic granules results in the secretion of granule enzymes (2, 22, 23) . Among the secretory products of this degranulation process is the azurophil granule constituent, myeloperoxidase (MPO) (24) (25) (26) (27) . The stimulated PMN also undergoes a burst of oxidative metabolism (2, 20, 21) which results in the extracellular release of various activated oxygen species, including H202 (28) (29) (30) . These components of the MPO system might be expected to react with extracellular halides to exert effects on host tissues present in the vicinity of the inflammatory response because the cell-free peroxidase system has been shown to affect a number of mammalian cells, including spermatozoa (31), erythrocytes (32) , leukocytes (33) , platelets (34) , and tumor cells (35, 36) . Furthermore, the effects of activated PMN on adjacent tumor cells (27, 37) and platelets (38) have been shown to be mediated in part by the MPO-H202-halide system.
Because the MPO system generates labile intermediates capable of reacting with a variety of substances, it was of interest to us to determine whether it might affect humoral mediators of the inflammatory process. In this report, we document the ability of MPO in combination with H202 and a halide to destroy the biological activity of two different leukocyte chemotactic factors, one of complement system origin and one a synthetic oligopeptide. The studies provide the basis for an inflammatory control mechanism involving the MPO system.
METHODS
Chemotacticfactors. The chemotactic fragment ofthe fifth component of complement was partially purified by a minor modification of a previously described technique (39) . Blood from normal adult volunteers was allowed to clot in glass tubes at room temperature for 1 h and the serum was harvested by centrifugation at 550 g for 10 min at 4°C. A 10-ml portion of serum was incubated with 5 mg of zymosan (ICN Nutritional Biochemicals, Cleveland, Ohio) for 1 h at 37°C and residual complement was then inactivated by heating at 56°C for 30 min. Zymosan was removed by centrifugation at 550 g for 20 min at 4°C and the activated serum was then subjected to miolecular seive chromatography on a 2.5 x 100-cm column of Sephadex G-75. Fractions were eluted with 0.05 M sodium phosphate buffer, pH 7.0, and tested for chemotactic activity. Essentially all ofthe activity was contained in fractions eluting just before cytochrome c, indicating an apparent mol wt of 13,000-15,000. The chemotactic activity in these pooled fractions was nearly completely inhibited by antibody to human C5, but not by antibody to human C3 (Meloy Laboratories Inc., Springfield, Va.). Currently available evidence indicates that the active material should be designated C5ades arg (40) , but for convenience will be referred to here as C5a.
The synthetic chemotactic peptide, N-formyl-methionylleucyl-phenylalanine (f-met-leu-phe), was kindly supplied by Dr. Elliot Schiffmann of the National Institute of Dental Research (Bethesda, Md.). It was dissolved at 10 mM in dimethyl sulfoxide and subsequent dilutionis were ma1zde in stetrile dlistilled water.
Chemlrotaxis assays. Chemotactic activity was (letermiie(d b)y two previously descril)ed methods, the 5mCr assay (41) ((C5a and some f-met-leu-phe experimiienits) and the leading froint assay (6) (f-met-leu-phe experiments). Blood was ob)tained from normal adult human volunteers and the PlMN hatrvested by dextrani sedimentation and hypotonic lysi s of erythrocytes.
For the 5'Cr assay, PMN were labeled with Na,'CrO4 (New England Nuclear, Boston, Mass., 200-500 .C'i1p.g Cr),
washed, and suspended in Gey's mediuml (Microbiological Associates, Walkersville, Md.) at 2.3 x 106 granulocvtes!ml (purity 80-90% granulocytes). For the lea(ding front assa., the labeling step was omitted, but washing ani(I suspenlsioIn in Gey's medium was the samile. In the ;"Cr assay, chambers were incubated for 3 h and chemiiotaxis was determiniedc as the imleanl counts per minute of 51Cr in the lower of two miiicropore filters (a 3-pn. imeain pore diameter, Sartorius Membranfilter, G6ttingen. West Germany). In the leading front assay, chambers wvere incubated for 1 h and chemnotaxis was determiinledias the mean depth of penetration in mieromileters into the filter (3-p.m pore, Sartorius) of the leading two cells. In both assays, eaclh sample was tested in four replicate chambers.
Expo.sure of chemotactic factors to the .IP() .siystemii. The chemotactic factors, C5a and f-met-leu-phe, were incubated with the components of the MPO systemn as detaile(d in the legends to the figures and tables. Each samuple containedl either 0.8 ml of C5a in a total volume of 1.0( ml of 40 mllM sodium phosphate buffer, pH 7.0, or 50 pmol of f-met-leu-phe in a total volume of 0.5 ml of 20 mM sodium phosphate buffer, pH 7.0. Incubations were performned in 12 x 75-mmil glass tubes in a 37°C water bath for 15 min, then placed in anl ice bath and diluted to a total volume of 4 ml with iced gelatinVeronal-buffered saline containing 70 p.M Ca2' and 0.5 mnM Mg2+. 0.8-ml aliquots were placed in the lower comilpartmiients of each of four chemotaxis chambers for the determiniationi of chemotactic activity. Controls in each experiment included samples without the chemiiotactic factor (backgroundi(l) aind samiiples with the chemotactic factor, but none of the comilponients of the MPO system (positive conitrol). After the chemniotactic activity in each sample was determined as either mean counts per minute (5mCr assay) or mean micrometers migration (leading front assay), the data were expressed as percent inactivation ofchemotactic activity accordiing to the following formula: Inactivation (percent) = (positive control-experimental sample)/(positive control-background(l) x 100. The mean background activity was 159±26 cpm (5mCr assay) or 62.8+3.4 p.m (leading front assay); the mean positive control for C5a was 1,281+131 cpm and for f-met-leu-phe was 627±66 (Table I) . This inactivation was comparable for both C5a and f-met-leu-phe and was documented with two different assays of PMN chemotaxis, the 5'Cr method and the leading front technique. The presence of MPO was essential for inactivation and this requirement was related to its enzymatic activity because heated MPO was ineffective and inactivation was blocked by azide (P < 0.001), an inhibitor of peroxidase activity. The amount of MPO employed in the experiments summarized in Table I was in excess of that required; under the same conditions, 1/10th as much MPO (1.6 mU/ml) plus H202 and chloride resulted in complete inactivation of f-met-leu-phe (104.9±5.5%, n = 8).
H202 was also an essential component of the system and could be supplied by either reagent H202 or a peroxide-generating enzyme system, glucose plus glucose oxidase. Furthermore, inactivation of the chemotactic agents was blocked by the peroxide-degrading enzyme, catalase (P < 0.001), but not by heat-inactivated catalase. Loss of activity on omission of chloride indicated a role for a halide and this requirement could be fulfilled by iodide or bromide, as well as by chloride.
Investigation ofthe time-course of inactivation of the chemoattractants demonstrated a rapid reaction (Fig.  1) . Using the standard concentrations of MPO, H2G2, and chloride, complete inactivation of f-met-leu-phe occurred within the 1st min of incubation. When lower concentrations ofreactants were used, a period of5-7.5 min was required for complete loss ofactivity. Inactivation was temperature-dependent because little or no loss of chemotactic activity was observed when f-metleu-phe was incubated in a melting ice bath (0°C) for 15 min with the MPO (4 mU/ml)-H202 (10 /M)-Cl-(10 mM) system; inactivation at 0°C was 11.4±14.4% compared with 92.0±5.9% in control samples incubated at 37°C (P < 0.001).
H202 alone is a reactive form of reduced oxygen, buffer pH 7.0 (total volume 1.0 ml) or 50 pmol f-met-leu-phe in 20 mM sodium phosphate buffer pH 7.0 (total volume 0.5 ml). The supplements listed were as follows: MPO, 16 mU/ml; H202, 10 j,M; sodium salts of Cl-, 0.1 M, I-, 1 mM, and Br-, 0.1 mM; sodium azide, 0.1 mM (C5a and f-met-leu-phe with leading front assay) or 1 mM (f-met-leu-phe with 5ICr assay); catalase, 4,200 U/ml; glucose, 10 mM; glucose oxidase, 3 mU/ml (C5a experiments) or 30 mU/ml (f-met-leu-phe experiments). MPO or catalase was heated at 100°C for 15 min where indicated. After incubation at 37°C for 15 min, all samples were diluted in gelatin-Veronal-buffered saline to a total volume of 4.0 ml and tested for chemotactic activity. FIGURE 1 Time-course of inactivation of f-met-leu-phe by the MPO system. The reaction mixture and supplements were the same as described in Table I for the MPO-H202-Cl-system (0) or the MPO and C1-concentrations were reduced to 4 mU/ml and 10 mM, respectively (0). The samples were incubated at 37°C for varying times as indicated and the reaction stopped by rapid cooling to 0°C and dilution in iced buffer. The zero time samples were kept at OC and iced buffer was added simultaneously with the MPO. The leading front assay of chemotaxis was used. The data shown are means of quadruplicate determinations in a single experiment; similar results were obtained in three additional experiments.
although its activity in microbicidal and cytotoxic systems is markedly enhanced by the addition of MPO and a halide (20, (32) (33) (34) (44) . The rank order observed for chemoattractant inactivation was similar with respect to chloride, although iodide and bromide were reversed (Fig. 3) . The concentrations of chloride, iodide, and bromide required for 50% inactivation were 0.5 mM, 50 ,uM, and 15 ,uM, respectively.
The most likely explanation ofthe findings described above is that the MPO system exerts its inhibitory effect on chemotaxis by the inactivation of the chemoattractant during the initial preincubation. An alternative possibility is that the peroxidase system components carried over into the chemotaxis chamber have an inhibitory effect on the assay of PMN migration, for example, by damaging the responding cells (33) . This possibility seemed unlikely because of the dilution of the MPO system components which occurred before the chemotaxis assay (Methods) and because the high concentration of protein present in the chemotaxis chamber might be expected to limit the toxicity of the MPO system (2). Furthermore, the lack of inactivation when the preincubation was short (Fig. 1) or was performed at 0°C rather than 37°C (see above) suggests that the loss of chemotactic activity occurred during the preincubation step. Two H202 (-1og10M) FIGURE 2 Inactivation of C5a by the MPO-H202-Cl-system and by H202 alone. The reaction mixture and supplements were the same as described in Table I for C5a and the 5'Cr assay. The effect of the MPO-H202-Cl-system with varying H202 concentrations (0) is compared with that of H202 alone (0). The data shown are means -+SE of five experiments. The activity of the complete MPO system is significant from 0.1 to 10 uM (P < 0.01 vs. control), whereas H202 had no significant activity (P > 0.05 vs. control).
HALIDE(-Iog1OM)
FIGURE 3 Inactivation of f-met-leu-phe by the MPO system with various halide cofactors. The reaction mixture and supplements were the same as described in Table I for 10 .0±+10.1 (4) tCatalase added:
Before preincubation 0.6+6.1 (4) After preincubation:
MPO system present 92.9+2.9 (3) MPO system absent 10.0±11.4 (3) * The reaction mixture and supplements were the same as described in Table I for C5a by the 5'Cr assay using the MPO-H202-Cl-system except that C5a was added either before or after the 15-min preincubation.
t The reaction mixture and supplements were the same as described in Table I for f-met-leu-phe by the leading front assay using the MPO-H202-Cl-system except that catalase (4,200 U/ml) was added either before or after the 15-min preincubation as indicated. In the latter case, the components of the MPO system were either included or omitted as indicated. § MeantSE, number of experiments in parentheses.
to the complete MPO system either before or after the 15-min preincubation at 37°C. As shown previously (Table I) , the former approach resulted in complete inactivation. In contrast, no significant inactivation was observed when the addition ofthe chemoattractant was withheld until the reaction mixture was placed on ice and diluted after the preincubation (Table II , chemoattractant added before vs. after preincubation-P < 0.001), indicating that the peroxidase system was not acting at a subsequent step (i.e., in the chemotaxis chamber). The second approach involved the termination of the MPO-H202-halide system activity by the addition ofcatalase either before or after the preincubation step. As previously demonstrated (Table I) , when catalase was added before the preincubation, inactivation of chemotaxis was prevented. However, when catalase was added to the MPO system-chemoattractant mixture after preincubation, no effect was observed; i.e., there was essentially complete inactivation of chemotaxis by the MPO system (Table II, catalase added before vs. after preincubation-P < 0.001), again indicating that the MPO system was exerting its effect during the preincubation and not during the subsequent chemotaxis assay. The incubation of catalase with the chemoattractant in the absence of the MPO system did not result in significant inhibition ofchemotaxis (Table II) . We also considered the possibility that exposure of a chemotactic peptide to the MPO system might modify the peptide to generate an inhibitor of chemotaxis. A small quantity of such an inhibitor could conceivably mask the chemotactic activity ofresidual intact peptide. This possibility was assessed by preincubating 50 pmol of f-met-leu-phe with the MPO-H202-Cl-system as in Table I and then adding an additional 50 pmol of f-metleu-phe before testing for chemotactic activity. Although complete loss of activity of the f-met-leu-phe present during the preincubation was observed as expected, the peptide added after the preincubation expressed full activity in the leading front chemotaxis assay (148.7±3.3 ,um compared with 143.1+4.6 ,um for control f-met-leu-phe assayed after preincubation in buffer alone without the MPO system). Thus, the MPOtreated peptide did not inhibit the activity ofthe added f-met-leu-phe, indicating that loss of activity on exposure to the MPO system was due to true inactivation rather than to the generation of an inhibitor.
DISCUSSION
The foregoing data indicate that the MPO-H202-halide system of the PMN is capable of destroying the biological activity of inflammatory mediators. Under the conditions employed, there was virtually complete inactivation of both a complement-derived chemotactic factor, C5a, and a synthetic peptide chemoattractant, f-met-leu-phe. Inactivation was demonstrated by two different assays of PMN chemotaxis, the 5tCr radiolabel method and the leading front technique. In each instance, loss ofchemotactic activity was dependent on each component of the system-MPO, H202, and a halide. Chemoattractant inactivation by the MPO system was rapid, being essentially complete within 1-5 min depending on the concentrations of reactants. The reaction was temperature-dependent because no significant inactivation occurred when the chemoattractant was incubated with the MPO system at 0°C rather than 37°C. The requirement for MPO was related to its enzymatic activity since heated peroxidase was ineffective. The H202 requirement was satisfied by either reagent peroxide or a peroxide-generating enzyme, glucose oxidase. Inactivation of the chemotactic factors was blocked by agents which inhibit MPO (azide) or degrade H202 (catalase). In the presence of MPO and a halide, H202 was effective at concentrations as low as 0.1 ,uM, although 10 ,uM was required for complete inactivation. H202 alone had little or no activity at levels as high as 10 mM. The order of effectiveness of halides as cofactors was Br-> I-> C1-, although only C1-supported complete inactivation at physiologic concentrations.
A number of potential mechanisms for controlling the inflammatory response have been described and several of these involve the inactivation of chemoattractants. Inactivating agents may be found in serum Chemotactic Factor Inactivation 917 or associated with leukocytes. Normal human serum contains chemotactic factor inactivators which degrade both complement-derived and bacterial chemoattractants (45, 46) , apparently functioning as aminopeptidases (47) . Serum carboxypeptidase B converts C5a to its desarginyl derivative with loss of anaphylatoxic, but not chemotactic activity (40) . PMN granule lysates contain proteases capable of inactivating chemotactic factors (8, 9, 15, 19) . The inactivation of C5a (15) and hydrolysis of the synthetic chemoattractant, formylnorleucyl-leucyl-phenylalanine (19) , was attributed to azurophil granule constituents and, in the case of C5a inactivation, two different agents with mol wt of 65,000 and 30,000 were detected (15) . Two purified human PMN granule neutral proteases, chymotrypsin-like cationic protein (cathepsin G) (14, 16) and elastase (16) , have been shown to inactivate C5a.
Other studies have indicated that PMN secrete agents into the extracellular fluid during phagocytosis or on exposure to soluble PMN activators which can inactivate C5a, synthetic chemotactic peptides, and bacterial chemotactic factors (8, 11, 15, 16, 19) . The identity of these secreted inactivators has not been securely established in most studies, although blocking of CSa inactivation by specific inhibitors of elastase (16) suggests that this neutral protease may be partially responsible. In other studies, the evidence suggested the participation oftwo different azurophil granule constituents (15) . It should be noted that proteases in PMN granule lysates and in extracellular fluid of activated PMN may generate as well as degrade C5a (8, 9, 12, (14) (15) (16) . In general, it appears that limited proteolytic cleavage ofthe C5 parent molecule results in the formation of biologically active C5a, but that more extensive proteolysis leads to cleavage of the C5a to an inactive product (9, 14, 16) .
Apart from the potential control of inflammation by PMN proteases through the formation and inactivation ofchemoattractants, it has been demonstrated that such enzymes are involved in the chemotactic response of the PMN; the potency of various f-met peptides as chemoattractants is related to the rate at which the peptides are hydrolyzed by the PMN (48) . Furthermore, chloromethyl ketone protease inhibitors block chemotaxis (48) . It was suggested that binding of the chemotactic peptide to a cell receptor results in peptide hydrolysis and that this process allows the sensing of the chemical gradient of the attractant. It is not known whether this peptidase is of granule origin or is associated with the cell membrane. Thus, its relationship to the chemoattractant-cleaving proteases detected in lysosomal lysates is unclear.
The mode of chemotactic factor inactivation observed in our studies is clearly different from the previously described proteolytic mechanisms. Unlike proteases, the MPO system requires H202 and a halide, indicating a peroxidative reaction. Although MPO is an azurophil granule constituent, its large molecular weight (49, 50) distinguishes it from the CSa-inactivating agents isolated from azurophil granules by Wright and Gallin (15) . Furthermore, the activities which these investigators observed did not depend on H2O2 or other products of oxygen metabolism. It is not surprising that MPO-mediated inactivation of chemoattractants has not been previously detected in studies using granule lysates or supernates of activated PMN. These preparations should contain MPO, but it is likely that any H202 initially present would have been dissipated and thus fresh H202 would have to be supplied. It remains to be seen whether stimulated PMN can inactivate chemoattractants by secretion of MPO and H202. However, such a sequence is quite plausible since activated PMNs are known to release these constituents of the MPO system into the extracellular fluid (24) (25) (26) (27) (28) (29) (30) . Among the stimuli inducing release of granule enzymes and metabolic products are chemotactic factors (2, 22, (51) (52) (53) (54) . These observations raise the interesting possibility that chemoattractants could initiate their own inactivation by triggering the release of either MPO and H202 or neutral proteases. The MPO system may, in addition, manifest other biological activities, including the lysis of mammalian cells (27, (31) (32) (33) (34) (35) (36) (37) (38) and the inactivation of other humoral mediators such as the slow-reacting substance of anaphylaxis (55) and serum antiproteases (56) ..
The molecular mechanism of MPO-catalyzed inactivation of chemoattractants has not been addressed in the experiments reported here. Two general mechanisms of MPO-mediated toxicity to microorganisms have been demonstrated, halogenation and oxidation (2, 20) . Halogenation involves the covalent binding of the halide cofactor to the target cell or molecule. Among the possible products formed with protein acceptors and iodide as the cofactor are iodotyrosines, iodohistidines, and sulfenyl iodides (2, 57) . The presence of these chemical configurations near the active site of the chemoattractant could account for the loss of biological activity. Oxidation reactions may be mediated by such peroxidase system intermediates as halogens, hypohalous acids, chloramines, aldehydes, and singlet molecular oxygen (2, 20) . A wide variety of oxidizable groups may be attacked. Of these, the thioether group of methionine may be especially pertinent because methionine is present both in the synthetic peptide attractant used in this study and in highly purified CSa (40) . The sulfone and sulfoxide derivatives of the f-met peptides are known to be inactive as chemoattractants (58) . Thus, methionine oxidation is a potential mechanism of action in our system. We are currently examining the role of both halogenation and oxidation reac- 
